Mitral Valve Surgery After Transcatheter Edge-to-Edge Repair: Mid-Term Outcomes From the CUTTING-EDGE International Registry
Tsuyoshi Kaneko,Sameer Hirji,Syed Zaid,Rudiger Lange,Jörg Kempfert,Lenard Conradi,Christian Hagl,Michael A Borger,Maurizio Taramasso,Tom C Nguyen,Gorav Ailawadi,Ashish S Shah,Robert L Smith,Amedeo Anselmi,Matthew A Romano,Walid Ben Ali,Basel Ramlawi,Kendra J Grubb,Newell B Robinson,Luigi Pirelli,Michael W A Chu,Martin Andreas,Jean-Francois Obadia,Marco Gennari,Andrea Garatti,Didier Tchetche,Tamim M Nazif,Vinayak N Bapat,Thomas Modine,Paolo Denti,Gilbert H L Tang,CUTTING-EDGE Investigators,Keti Vitanova,Markus Krane,Serdar Akansel,Oliver D Bhadra,Shekhar Saha,Erik Bagaev,Thilo Noack,Florian Fahr,Guido Ascione,Ana Paula Tagliari,Alejandro Pizano,Marissa Donatelle,Kashish Goel,John J Squiers,Pinak B Shah,Guillaume Leurent,Herve Corbineau,Anita W Asgar,Philippe Demers,Michel Pellerin,Denis Bouchard,Chawannuch Ruaengsri,Lin Wang,George A Petrossian,Chad A Kliger,Lionel Leroux,Muhanad Algadheeb,Shahar Lavi,Paul Werner,Michele Flagiello,Antonio L Bartorelli,Angie Ghattas,Nicholas Dumonteil,Moritz Wyler von Ballmoos,Marvin D Atkins,Augusto D'Onofrio,Chiara Tessari,Arnar Geirsson,Ryan K Kaple,Francesco Massi,Michele Triggiani,Eric Van Belle,Flavien Vincent,Tom Denimal,Christina Brinkmann,Joachim Schöfer,Marco Di Eusanio,Filippo Capestro,Rodrigo Estevez-Loureiro,Miguel A Pinon,Neal S Kleiman,Michael J Reardon,Molly I Szerlip,J Michael DiMaio,Michael J Mack,D Scott Lim,Volkmar Falk,Francesco Maisano,Isaac George,Rebecca T Hahn
DOI: https://doi.org/10.1016/j.jcin.2021.07.029
2021-09-27
Abstract:Objectives: The aim of this study was to determine clinical and echocardiographic characteristics, mechanisms of failure, and outcomes of mitral valve (MV) surgery after transcatheter edge-to-edge repair (TEER). Background: Although >100,000 mitral TEER procedures have been performed worldwide, longitudinal data on MV surgery after TEER are lacking. Methods: Data from the multicenter, international CUTTING-EDGE registry were retrospectively analyzed. Clinical and echocardiographic outcomes were evaluated. Median follow-up duration was 9.0 months (interquartile range [IQR]: 1.2-25.7 months) after MV surgery, and follow-up was 96.1% complete at 30 days and 81.1% complete at 1 year. Results: From July 2009 to July 2020, 332 patients across 34 centers underwent MV surgery after TEER. The mean age was 73.8 ± 10.1 years, median Society of Thoracic Surgeons risk for MV repair at initial TEER was 4.0 (IQR: 2.3-7.3), and primary/mixed and secondary mitral regurgitation were present in 59.0% and 38.5%, respectively. The median interval from TEER to surgery was 3.5 months (IQR: 0.5-11.9 months), with overall median Society of Thoracic Surgeons risk of 4.8% for MV replacement (IQR: 2.8%-8.4%). The primary indication for surgery was recurrent mitral regurgitation (33.5%), and MV replacement and concomitant tricuspid surgery were performed in 92.5% and 42.2% of patients, respectively. The 30-day and 1-year mortality rates were 16.6% and 31.3%, respectively. On Kaplan-Meier analysis, the actuarial estimates of mortality were 24.1% at 1 year and 31.7% at 3 years after MV surgery. Conclusions: In this first report of the CUTTING-EDGE registry, the mortality and morbidity risks of MV surgery after TEER were not negligible, and only <10% of patients underwent MV repair. These registry data provide valuable insights for further research to improve these outcomes.